Seki Co., Ltd.
Seki Co., Ltd. (7857.T) Financial Performance & Income Statement Overview
Review Seki Co., Ltd. (7857.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Seki Co., Ltd. (7857.T) Income Statement & Financial Overview
Analyze Seki Co., Ltd.’s 7857.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.27B | $3.23B | $3.01B | $2.80B |
| Cost of Revenue | $2.41B | $2.49B | $2.32B | $2.21B |
| Gross Profit | $859.00M | $736.00M | $694.00M | $586.00M |
| Gross Profit Ratio | $0.26 | $0.23 | $0.23 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $683.00M | $681.00M | $650.00M | $636.00M |
| Operating Expenses | $684.00M | $682.00M | $649.00M | $636.00M |
| Total Costs & Expenses | $3.10B | $3.17B | $2.96B | $2.85B |
| Interest Income | $1.35M | $2.04M | $652000.00 | $68.00M |
| Interest Expense | $643000.00 | $674000.00 | $733000.00 | $0.00 |
| Depreciation & Amortization | $102.75M | $124.00M | $100.50M | $124.00M |
| EBITDA | $278.75M | $179.00M | $144.50M | $74.00M |
| EBITDA Ratio | $0.09 | $0.06 | $0.05 | $0.03 |
| Operating Income | $175.00M | $54.00M | $45.00M | -$50.00M |
| Operating Income Ratio | $0.05 | $0.02 | $0.01 | -$0.02 |
| Other Income/Expenses (Net) | $33.00M | $60.00M | $48.00M | $95.00M |
| Income Before Tax | $208.00M | $114.00M | $93.00M | $45.00M |
| Income Before Tax Ratio | $0.06 | $0.04 | $0.03 | $0.02 |
| Income Tax Expense | $79.00M | $28.00M | $44.00M | $17.00M |
| Net Income | $125.00M | $82.00M | $48.00M | $25.00M |
| Net Income Ratio | $0.04 | $0.03 | $0.02 | $0.009 |
| EPS | $30.01 | $19.69 | $11.52 | $6.00 |
| Diluted EPS | $30.01 | $19.69 | $11.52 | $6.00 |
| Weighted Avg Shares Outstanding | $4.17M | $4.17M | $4.17M | $4.17M |
| Weighted Avg Shares Outstanding (Diluted) | $4.17M | $4.17M | $4.17M | $4.17M |
The company's financials show resilient growth, with revenue advancing from $2.80B in Q1 2024 to $3.27B in Q4 2024. Gross profit remained healthy with margins at 26% in Q4 2024 compared to 21% in Q1 2024. Operating income hit $175.00M last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $278.75M. Net income rose to $125.00M, while earnings per share reached $30.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan